Article
FSCN1 Modulates Tumor Growth and Innate Immune Pathways through Synergistic Interaction with PIK3CA Mutations
2025-06-26
Abstract excerpt
<title>Abstract</title> <p>Background Tumor-specific genetic alterations critically drive cancer progression and therapeutic resistance through both cell- and non-cell-autonomous mechanisms. While the actin-binding protein FSCN1 has been linked to tumor progression, its role in shaping immune evasion and tumor growth in PIK3CA-mutant cancers remains poorly understood. This study investigated the mechanism by whi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 71a7af1b-4cd8-5283-9aee-26da6f243414
- DOI
- 10.21203/rs.3.rs-6662400/v1
